Aditya, S. (2017). Ivacaftor in cystic fibrosis: the first disease modifying agent. International Journal of Basic & Clinical Pharmacology, 1(3), 225–229. Retrieved from https://www.ijbcp.com/index.php/ijbcp/article/view/1433